106 related articles for article (PubMed ID: 60118)
1. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1976 Jul; 34(1):1-6. PubMed ID: 60118
[TBL] [Abstract][Full Text] [Related]
2. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
3. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
4. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
Rawlins GA; Wood JM; Bagshawe KD
Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.
Shi YD; Tang ZS; Lian ZJ; Lu CZ; Xiao BG
Br J Cancer; 1981 Apr; 43(4):532-6. PubMed ID: 6165370
[No Abstract] [Full Text] [Related]
6. Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.
Shaw A; Ettin G; McPherson TA
Br J Cancer; 1976 Jul; 34(1):7-13. PubMed ID: 60119
[TBL] [Abstract][Full Text] [Related]
7. The clinical assessment of cancer tests: a statistical approach to the prediction of "false positive" rates from controls.
Sutherland WH; Pritchard JA; Smith CW
Ann Clin Res; 1977 Apr; 9(2):45-51. PubMed ID: 883757
[TBL] [Abstract][Full Text] [Related]
8. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
Crozier EH; Hollinger ME; Woodend BE; Robertson JH
J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
[TBL] [Abstract][Full Text] [Related]
9. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
12. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
Lewkonia RM; Kerr EJ; Irvine WJ
Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
[TBL] [Abstract][Full Text] [Related]
14. Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein.
Gouda Z; Thomson DM
Jpn J Cancer Res; 1988 Apr; 79(4):529-37. PubMed ID: 2454907
[TBL] [Abstract][Full Text] [Related]
15. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
17. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data.
Kast RE
Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596
[TBL] [Abstract][Full Text] [Related]
18. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
Tautz C; Schneider W; Laier E; Brügmann G
Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
[No Abstract] [Full Text] [Related]
19. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
20. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
